| rs1919314 |
chr7 |
18140361 |
0.00000105 |
A |
T |
Colorectal adenoma |
HDAC9 |
intron |
23677573
|
| rs1919314 |
chr7 |
18140361 |
0.00000105 |
A |
T |
Colorectal adenoma (including hyperplasic) |
HDAC9 |
intron |
23677573
|
| rs1919314 |
chr7 |
18140361 |
0.00000137 |
A |
T |
Colorectal adenoma (excluding hyperplasic) |
HDAC9 |
intron |
23677573
|
| rs2731564 |
chr7 |
18150431 |
0.0000443 |
G |
A |
Waist Circumference |
HDAC9 |
intron |
pha003023
|
| rs4490725 |
chr7 |
18172374 |
0.000511 |
A |
G |
Alzheimer's disease |
HDAC9 |
intron |
17998437
|
| rs12536864 |
chr7 |
18218581 |
0.00000791 |
A |
G |
Retinopathy in non-diabetics |
HDAC9 |
intron |
23393555
|
| rs11489326 |
chr7 |
18244502 |
0.000224 |
C |
T |
Multiple complex diseases |
HDAC9 |
intron |
17554300
|
| rs2529749 |
chr7 |
18253060 |
0.000869 |
A |
C |
Blood pressure,CVD RF and other traits (body mass index (BMI),waist:hip ratio,renin activity in plasma,aldosterone concentration in plasma,BNP levels in plasma,alcohol consumption) |
HDAC9 |
intron |
20877124
|
| rs302132 |
chr7 |
18278088 |
0.000054 |
C |
G |
Response to lithium treatment in bipolar disorder |
HDAC9 |
intron |
19448189
|
| rs302147 |
chr7 |
18285373 |
0.000000000000016 |
C |
T |
Narcolepsy |
HDAC9 |
intron |
19629137
|
| rs917325 |
chr7 |
18288593 |
0.000725 |
A |
G |
Blood pressure,CVD RF and other traits (body mass index (BMI),waist:hip ratio,renin activity in plasma,aldosterone concentration in plasma,BNP levels in plasma,alcohol consumption) |
HDAC9 |
intron |
20877124
|
| rs215122 |
chr7 |
18295790 |
0.000307 |
C |
T |
Blood pressure,CVD RF and other traits (body mass index (BMI),waist:hip ratio,renin activity in plasma,aldosterone concentration in plasma,BNP levels in plasma,alcohol consumption) |
HDAC9 |
intron |
20877124
|
| rs625733 |
chr7 |
18328568 |
0.0000258 |
G |
T |
Multiple complex diseases |
HDAC9 |
intron |
17554300
|
| rs2791300 |
chr7 |
18329077 |
0.000077 |
C |
G |
Type 2 diabetes |
HDAC9 |
intron |
17463248
|
| rs590099 |
chr7 |
18336338 |
0.000026 |
G |
A |
Primary sclerosing cholangitis |
HDAC9 |
intron |
22521342
|
| rs4721708 |
chr7 |
18370302 |
0.0000038 |
T |
C |
Type 2 diabetes |
HDAC9 |
intron |
17463248
|
| rs12666612 |
chr7 |
18375245 |
0.000008 |
T |
C |
Obesity-related traits |
HDAC9 |
intron |
23251661
|
| rs596844 |
chr7 |
18383364 |
0.000263 |
C |
T |
Alzheimer's disease |
HDAC9 |
intron |
17998437
|
| rs615545 |
chr7 |
18391871 |
0.0000059 |
C |
T |
Type 2 diabetes |
HDAC9 |
intron |
17463248
|
| rs1365893 |
chr7 |
18404917 |
0.000014 |
C |
A |
Response to alcohol consumption (flushing response) |
HDAC9 |
intron |
24277619
|
| rs10486301 |
chr7 |
18409781 |
0.000194 |
T |
C |
Bone mass and geometry |
HDAC9 |
intron |
17903296
|
| rs10486301 |
chr7 |
18409781 |
0.000027 |
T |
C |
Obesity-related traits |
HDAC9 |
intron |
17903300
|
| rs10236525 |
chr7 |
18411672 |
0.00055 |
T |
C |
Obesity-related traits |
HDAC9 |
intron |
17903300
|
| rs12155400 |
chr7 |
18428921 |
0.000008 |
A |
G |
Retinopathy in non-diabetics |
HDAC9 |
intron |
23393555
|
| rs2012064 |
chr7 |
18447324 |
0.00045 |
G |
C |
Obesity-related traits |
HDAC9 |
intron |
17903300
|
| rs2162563 |
chr7 |
18450104 |
0.000881 |
G |
A |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs11977093 |
chr7 |
18485913 |
0.000528 |
T |
C |
Response to taxane treatment (placlitaxel) |
HDAC9 |
intron |
23006423
|
| rs213273 |
chr7 |
18504508 |
0.00000002 |
G |
A |
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) |
HDAC9 |
intron |
24554482
|
| rs17432356 |
chr7 |
18524133 |
0.000715 |
C |
T |
Multiple complex diseases |
HDAC9 |
intron |
17554300
|
| rs2188495 |
chr7 |
18540461 |
0.000671 |
A |
C |
Tourette syndrome |
HDAC9 |
intron |
22889924
|
| rs17432448 |
chr7 |
18548419 |
0.00016 |
A |
G |
Blood pressure |
HDAC9 |
intron |
21909110
|
| rs13231835 |
chr7 |
18565058 |
0.00002 |
T |
C |
Diastolic blood pressure |
HDAC9 |
intron |
19430483
|
| rs140585698 |
chr7 |
18631217 |
0.000098 |
C |
G |
Prostate cancer (advanced) |
HDAC9 |
missense |
23555315
|
| rs3814991 |
chr7 |
18634903 |
0.000146 |
T |
C |
Gains in maximal O2 uptake response |
HDAC9 |
intron |
21183627
|
| rs3814991 |
chr7 |
18634903 |
0.000389 |
T |
C |
Stroke |
HDAC9 |
intron |
pha002886
|
| rs1554772 |
chr7 |
18638811 |
0.0000095 |
C |
G |
Urinary metabolites |
HDAC9 |
intron |
21572414
|
| rs2254993 |
chr7 |
18647887 |
0.000795 |
A |
G |
Amyotrophic lateral sclerosis (sporadic) |
HDAC9 |
intron |
24529757
|
| rs6963748 |
chr7 |
18666217 |
0.000012 |
C |
T |
Cognitive impairment induced by topiramate |
HDAC9 |
intron |
22091778
|
| rs6963748 |
chr7 |
18666217 |
0.000363 |
C |
T |
Response to cytadine analogues (cytosine arabinoside) |
HDAC9 |
intron |
24483146
|
| rs17432977 |
chr7 |
18666597 |
0.000843 |
C |
T |
Response to cytadine analogues (cytosine arabinoside) |
HDAC9 |
intron |
24483146
|
| rs2285437 |
chr7 |
18681992 |
0.000022 |
C |
G |
Urinary metabolites |
HDAC9 |
intron |
21572414
|
| rs3801983 |
chr7 |
18683672 |
0.000207 |
T |
C |
Blood pressure |
HDAC9 |
intron |
17255346
|
| rs2239927 |
chr7 |
18689883 |
0.000212 |
G |
T |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs6979890 |
chr7 |
18693393 |
0.000617 |
A |
G |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs6979890 |
chr7 |
18693393 |
0.000435 |
A |
G |
Gallstones |
HDAC9 |
intron |
17632509
|
| rs6979890 |
chr7 |
18693393 |
0.000912 |
A |
G |
Type 2 diabetes |
HDAC9 |
intron |
22238593
|
| rs6973063 |
chr7 |
18697589 |
0.000462 |
A |
G |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs2269752 |
chr7 |
18699285 |
0.0000475 |
C |
A |
Stroke |
HDAC9 |
intron |
pha002886
|
| rs2269753 |
chr7 |
18699466 |
0.000462 |
A |
T |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs2269754 |
chr7 |
18699475 |
0.000462 |
A |
G |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs2285443 |
chr7 |
18704889 |
0.000144 |
G |
A |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs801524 |
chr7 |
18706918 |
0.000146 |
G |
A |
Blood pressure |
HDAC9 |
UTR-3 |
17255346
|
| rs801524 |
chr7 |
18706918 |
0.000126 |
G |
A |
Type 2 diabetes |
HDAC9 |
UTR-3 |
17463246
|
| rs706087 |
chr7 |
18713515 |
0.000462 |
A |
G |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs17139571 |
chr7 |
18714254 |
0.0000615 |
T |
G |
Brain derived neurotrophic factor levels,in serum |
HDAC9 |
intron |
22047184
|
| rs756790 |
chr7 |
18714381 |
0.000462 |
G |
A |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs61584435 |
chr7 |
18717509 |
0.00000415 |
T |
G |
PR interval in Tripanosoma cruzi seropositivity |
HDAC9 |
intron |
24324551
|
| rs4484585 |
chr7 |
18718573 |
0.00000674 |
C |
A |
Brain derived neurotrophic factor levels,in serum |
HDAC9 |
intron |
22047184
|
| rs4484585 |
chr7 |
18718573 |
0.000614 |
C |
A |
Stroke |
HDAC9 |
intron |
pha002886
|
| rs73313346 |
chr7 |
18723232 |
0.000004 |
T |
C |
PR interval in Tripanosoma cruzi seropositivity |
HDAC9 |
intron |
24324551
|
| rs2106362 |
chr7 |
18725261 |
0.000446 |
C |
G |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs6950376 |
chr7 |
18728485 |
0.000315 |
A |
G |
Height |
HDAC9 |
intron |
17255346
|
| rs17139658 |
chr7 |
18730268 |
0.000086 |
T |
C |
Brain derived neurotrophic factor levels,in serum |
HDAC9 |
intron |
22047184
|
| rs12669789 |
chr7 |
18734065 |
0.000953 |
T |
C |
Stroke |
HDAC9 |
intron |
pha002886
|
| rs212667 |
chr7 |
18739315 |
0.000724 |
G |
A |
Smoking initiation |
HDAC9 |
intron |
24665060
|
| rs1178118 |
chr7 |
18751998 |
0.000628 |
T |
C |
Stroke |
HDAC9 |
intron |
pha002887
|
| rs6952102 |
chr7 |
18753386 |
0.000252 |
G |
A |
Blood pressure |
HDAC9 |
intron |
17255346
|
| rs4721722 |
chr7 |
18755646 |
0.000327 |
T |
C |
Blood pressure |
HDAC9 |
intron |
17255346
|
| rs17139817 |
chr7 |
18795250 |
0.0000588 |
T |
G |
Alzheimer's disease |
HDAC9 |
intron |
24755620
|
| rs11764116 |
chr7 |
18800413 |
0.000002 |
G |
T |
Ulcerative colitis |
HDAC9 |
intron |
20848476
|
| rs17139857 |
chr7 |
18802346 |
0.000893 |
T |
C |
Multiple complex diseases |
HDAC9 |
intron |
17554300
|
| rs17139867 |
chr7 |
18802944 |
0.000877 |
A |
G |
Multiple complex diseases |
HDAC9 |
intron |
17554300
|
| rs6958865 |
chr7 |
18805948 |
0.000153 |
A |
G |
Alzheimer's disease (late onset) |
HDAC9 |
intron |
21379329
|
| rs6958865 |
chr7 |
18805948 |
0.00000596 |
A |
G |
Alzheimer's disease |
HDAC9 |
intron |
24755620
|
| rs2519739 |
chr7 |
18812445 |
0.000000438 |
C |
A |
Cognitive test performance |
HDAC9 |
intron |
20125193
|
| rs10261308 |
chr7 |
18839183 |
0.000254 |
A |
C |
Alzheimer's disease |
HDAC9 |
intron |
24755620
|
| rs17140017 |
chr7 |
18855192 |
0.000495 |
A |
C |
Multiple complex diseases |
HDAC9 |
intron |
17554300
|
| rs3852256 |
chr7 |
18866844 |
0.0000000216 |
A |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs17349860 |
chr7 |
18868031 |
0.00000000866 |
C |
T |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs3852257 |
chr7 |
18871692 |
0.0000000000675 |
C |
T |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs2016515 |
chr7 |
18874385 |
0.000000000975 |
T |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs13238389 |
chr7 |
18876899 |
0.0000000000146 |
C |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs957960 |
chr7 |
18877408 |
0.00000000232 |
C |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs957958 |
chr7 |
18877616 |
0.00000000000145 |
A |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs2073963 |
chr7 |
18877874 |
0.000000000001 |
T |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs2073964 |
chr7 |
18878150 |
0.00000000000306 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs12536836 |
chr7 |
18881075 |
0.0000000000406 |
C |
T |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6461386 |
chr7 |
18883690 |
0.00000000219 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs756853 |
chr7 |
18890000 |
0.000326 |
G |
A |
Coronary Artery Disease |
HDAC9 |
intron |
17634449
|
| rs756853 |
chr7 |
18890000 |
0.000000000014 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs13245206 |
chr7 |
18891259 |
0.000739 |
G |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs13245206 |
chr7 |
18891259 |
0.0000000000133 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs10230371 |
chr7 |
18894897 |
0.0000000000139 |
T |
C |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs12699994 |
chr7 |
18895297 |
0.000125 |
C |
T |
Coronary Artery Disease |
HDAC9 |
intron |
17634449
|
| rs2249817 |
chr7 |
18896011 |
0.0000000000156 |
A |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6461387 |
chr7 |
18898305 |
0.000759 |
G |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6461387 |
chr7 |
18898305 |
0.0000000000324 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs756854 |
chr7 |
18903015 |
0.00084 |
C |
T |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs756854 |
chr7 |
18903015 |
0.000000000139 |
C |
T |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6461389 |
chr7 |
18907030 |
0.000296 |
C |
T |
Coronary Artery Disease |
HDAC9 |
intron |
17634449
|
| rs6461389 |
chr7 |
18907030 |
0.000313 |
C |
T |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6973029 |
chr7 |
18908850 |
0.000294 |
C |
T |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6461390 |
chr7 |
18910232 |
0.000231 |
A |
G |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6461390 |
chr7 |
18910232 |
0.0000000244 |
A |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6951144 |
chr7 |
18911789 |
0.00053 |
C |
G |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6951144 |
chr7 |
18911789 |
0.0000000195 |
C |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6951745 |
chr7 |
18911957 |
0.000396 |
G |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6951745 |
chr7 |
18911957 |
0.0000000132 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6461392 |
chr7 |
18912802 |
0.000401 |
G |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6461392 |
chr7 |
18912802 |
0.0000000124 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6461393 |
chr7 |
18912815 |
0.000306 |
T |
G |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6461393 |
chr7 |
18912815 |
0.0000000289 |
T |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6461394 |
chr7 |
18912890 |
0.00044 |
C |
G |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs6461394 |
chr7 |
18912890 |
0.00000000954 |
C |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs7794241 |
chr7 |
18913380 |
0.000274 |
C |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs7794241 |
chr7 |
18913380 |
0.0000000267 |
C |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs2286213 |
chr7 |
18914251 |
0.000304 |
C |
G |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs2286213 |
chr7 |
18914251 |
0.000000026 |
C |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs6959501 |
chr7 |
18915133 |
0.000923 |
T |
C |
Type 2 diabetes |
HDAC9 |
intron |
17463246
|
| rs10237149 |
chr7 |
18915426 |
0.00021 |
G |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs10237149 |
chr7 |
18915426 |
0.0000000373 |
G |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs10237366 |
chr7 |
18915559 |
0.000268 |
G |
C |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs10237366 |
chr7 |
18915559 |
0.0000000456 |
G |
C |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs10237280 |
chr7 |
18915666 |
0.000269 |
C |
T |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs10237280 |
chr7 |
18915666 |
0.0000000349 |
C |
T |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs13233322 |
chr7 |
18915701 |
0.000141 |
C |
A |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs13233322 |
chr7 |
18915701 |
0.0000000381 |
C |
A |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs10486314 |
chr7 |
18915874 |
0.000157 |
A |
G |
Depression (quantitative trait) |
HDAC9 |
intron |
20800221
|
| rs10486314 |
chr7 |
18915874 |
0.0000000496 |
A |
G |
Male-pattern baldness |
HDAC9 |
intron |
22693459
|
| rs7811991 |
chr7 |
18918559 |
0.0000124 |
T |
C |
Multiple sclerosis (brain glutamate levels) |
HDAC9 |
intron |
20802204
|
| rs10486317 |
chr7 |
18935733 |
0.000793 |
G |
A |
Blood pressure,CVD RF and other traits (body mass index (BMI),waist:hip ratio,renin activity in plasma,aldosterone concentration in plasma,BNP levels in plasma,alcohol consumption) |
HDAC9 |
intron |
20877124
|
| rs201664762 |
chr7 |
18938958 |
0.000071 |
T |
TC |
Coronary heart disease |
HDAC9 |
intron |
pha003030
|
| rs2301949 |
chr7 |
18938958 |
0.000071 |
T |
C |
Coronary heart disease |
HDAC9 |
intron |
pha003030
|
| rs17350515 |
chr7 |
18941624 |
0.00019 |
G |
A |
Response to taxane treatment (placlitaxel) |
HDAC9 |
intron |
23006423
|
| rs2853552 |
chr7 |
18980267 |
0.000007 |
A |
G |
Obesity-related traits |
HDAC9 |
intron |
23251661
|
| rs2717344 |
chr7 |
19030853 |
0.0000258 |
G |
A |
Cytomegalovirus antibody response |
HDAC9 |
intron |
21993531
|
| rs11984041 |
chr7 |
19031935 |
0.00000000002 |
C |
T |
Stroke |
HDAC9 |
intron |
22306652
|
| rs7788972 |
chr7 |
19034280 |
0.0000373 |
T |
A |
Aging (time to event) |
HDAC9 |
intron |
21782286
|
| rs7788972 |
chr7 |
19034280 |
0.000047 |
T |
A |
Blood pressure |
HDAC9 |
intron |
21909110
|
| rs2023938 |
chr7 |
19036775 |
0.000023 |
T |
C |
Coronary artery disease (CAD) (males) |
HDAC9 |
UTR-3 |
23202125
|
| rs2023938 |
chr7 |
19036775 |
0.000171 |
T |
C |
Coronary artery disease (CAD) age >50 |
HDAC9 |
UTR-3 |
23202125
|
| rs2023938 |
chr7 |
19036775 |
0.000000000359 |
T |
C |
Coronary artery disease |
HDAC9 |
UTR-3 |
23202125
|
| rs2023938 |
chr7 |
19036775 |
0.00000165 |
T |
C |
Stroke (ischemic) |
HDAC9 |
UTR-3 |
24262325
|
| rs2023938 |
chr7 |
19036775 |
0.00000000233 |
T |
C |
Large artery stroke |
HDAC9 |
UTR-3 |
24262325
|
| rs7776735 |
chr7 |
19036909 |
0.000598 |
T |
C |
Depression (quantitative trait) |
HDAC9 |
UTR-3 |
20800221
|